Clinical trials
Terminated Phase 2/3 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 30 |
| 2021 | 15 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Invivyd, Inc. | 2 |
| Pfizer | 2 |
| Abivax S.A. | 1 |
| Adamis Pharmaceuticals Corporation | 1 |
| Advagene Biopharma Co. Ltd. | 1 |
| Bassett Healthcare | 1 |
| Biophytis | 1 |
| Boehringer Ingelheim | 1 |
| Cardiol Therapeutics Inc. | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 50 |
| Coronavirus Infections | 8 |
| Pneumonia | 4 |
| Cytokine Release Syndrome | 2 |
| Severe Acute Respiratory Syndrome | 2 |
| Acute Lung Injury | 1 |
| Cardiovascular Diseases | 1 |
| Communicable Diseases, Emerging | 1 |
| Dyspnea | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.